Excessively activated plasminogen in human plasma cleaves VWF multimers and reduces collagen-binding activity

Kenshi Togashi1, Satoshi Suzuki2, Sae Morita3

  • 1Graduate School of Engineering.

Insights

Streptokinase-activated plasmin degrades von Willebrand factor multimers, impairing collagen binding and affecting primary hemostasis. This suggests potential issues with both primary and secondary hemostasis in blood.

Area of Science:

  • Biochemistry
  • Hematology
  • Physiology

Background:

  • Plasmin (Pm) is a serine protease primarily known for its role in fibrinolysis.
  • Potential functions of plasmin beyond fibrin clot dissolution in blood require further investigation.
  • Understanding plasmin's interaction with von Willebrand factor (VWF) is crucial for evaluating its role in primary hemostasis.

Purpose of the Study:

  • To investigate the effects of plasmin on primary hemostasis.
  • To evaluate the cleavage of von Willebrand factor multimers (VWFMs) by streptokinase-activated plasminogen (Pg).
  • To assess the impact of VWFMs cleavage on their binding ability to collagen.

Main Methods:

  • Analysis of VWFMs cleavage in human plasma by streptokinase-activated plasminogen (Pg) and ADAMTS13.
  • Comparison of VWFMs cleavage under static conditions (urea buffer dialysis) versus dynamic conditions (vortex-based shear stress).
  • Assessment of VWFMs binding capacity to collagen after enzymatic digestion.

Main Results:

  • Both SK-activated Pg and ADAMTS13 cleaved VWFMs in a conformation-dependent manner under static conditions.
  • Under shear stress, SK-activated Pg cleaved VWFMs, whereas ADAMTS13 did not, indicating shear-dependent exposure of cleavage sites.
  • Cleavage by SK-activated Pg significantly reduced VWFMs' binding ability to collagen.

Conclusions:

  • Streptokinase-activated plasmin degrades VWFMs and impairs their collagen-binding function, thereby affecting primary hemostasis.
  • The findings suggest that excessive plasminogen activation may lead to impaired primary and secondary hemostasis due to VWF degradation.
  • This highlights a potential mechanism by which plasmin can influence hemostatic balance beyond its fibrinolytic activity.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
211